JP2024519195A5 - - Google Patents
Info
- Publication number
- JP2024519195A5 JP2024519195A5 JP2023564484A JP2023564484A JP2024519195A5 JP 2024519195 A5 JP2024519195 A5 JP 2024519195A5 JP 2023564484 A JP2023564484 A JP 2023564484A JP 2023564484 A JP2023564484 A JP 2023564484A JP 2024519195 A5 JP2024519195 A5 JP 2024519195A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- galectin
- particle according
- antigen
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163178755P | 2021-04-23 | 2021-04-23 | |
| US63/178,755 | 2021-04-23 | ||
| PCT/JP2022/018610 WO2022225057A1 (en) | 2021-04-23 | 2022-04-22 | Galectin-targeting immunotherapy |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024519195A JP2024519195A (ja) | 2024-05-09 |
| JP2024519195A5 true JP2024519195A5 (https=) | 2025-04-21 |
Family
ID=83723024
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023564484A Pending JP2024519195A (ja) | 2021-04-23 | 2022-04-22 | ガレクチン標的の免疫療法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220347261A1 (https=) |
| EP (1) | EP4326858A4 (https=) |
| JP (1) | JP2024519195A (https=) |
| CN (1) | CN117222734A (https=) |
| WO (1) | WO2022225057A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN119546752A (zh) * | 2022-04-18 | 2025-02-28 | Cyn-K 生物公司 | 炎性病况的治疗 |
| WO2025084276A1 (ja) * | 2023-10-16 | 2025-04-24 | Ｃｙｎ－Ｋバイオ株式会社 | 肥満の処置 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6753314B1 (en) * | 1999-04-01 | 2004-06-22 | Curagen Corporation | Protein-protein complexes and methods of using same |
| EP2370455B1 (en) * | 2008-11-26 | 2019-07-03 | Government of the United States of America, as represented by the Secretary, Department of Health and Human Services | Virus like particle compositions and methods of use |
| US9969986B2 (en) * | 2014-08-08 | 2018-05-15 | Vlp Therapeutics, Llc | Virus like particle comprising modified envelope protein E3 |
| MY189596A (en) * | 2015-07-15 | 2022-02-18 | Immatics Biotechnologies Gmbh | A novel peptides for use in immunotherapy against epithelial ovarian cancer and other cancers |
| SE1500434A1 (en) * | 2015-10-29 | 2017-04-30 | Theravac Pharmaceuticals Ab | A novel fusion partner for highly efficient and safe vaccines |
| CN118108847A (zh) * | 2016-08-07 | 2024-05-31 | 诺华股份有限公司 | mRNA介导的免疫方法 |
| WO2018138257A1 (en) * | 2017-01-27 | 2018-08-02 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers |
| SI3573647T1 (sl) * | 2017-01-27 | 2023-07-31 | Immatics Biotechnologies Gmbh | Peptidi in kombinacija peptidov za uporabo v imunoterapiji proti raku jajčnikov in drugim oblikam raka |
| US11407797B2 (en) * | 2017-10-11 | 2022-08-09 | University Of Florida Research Foundation, Incorporated | Modified gal-1 proteins and uses thereof |
-
2022
- 2022-04-22 EP EP22791828.1A patent/EP4326858A4/en active Pending
- 2022-04-22 JP JP2023564484A patent/JP2024519195A/ja active Pending
- 2022-04-22 US US17/726,623 patent/US20220347261A1/en active Pending
- 2022-04-22 WO PCT/JP2022/018610 patent/WO2022225057A1/en not_active Ceased
- 2022-04-22 CN CN202280030030.XA patent/CN117222734A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106471125B (zh) | 包括白蛋白结合部分的腺病毒 | |
| EP3292142B1 (en) | Oncolytic adenoviruses with mutations in immunodominant adenovirus epitopes and their use in cancer treatment | |
| JP2022163182A5 (https=) | ||
| JP5746823B2 (ja) | Ｅ３−１９ｋタンパク質の小胞体保持ドメインに突然変異を有するアデノウイルス及び癌治療におけるその用途 | |
| JP2022051775A5 (https=) | ||
| WO2022206222A1 (zh) | 一种新型冠状病毒s-rbd三聚体蛋白疫苗、其制备方法和应用 | |
| JP2024519195A5 (https=) | ||
| US10435712B2 (en) | Evolution of high-titer virus-like vesicles for vaccine applications | |
| CN116082521A (zh) | 痘病毒多抗原嵌合疫苗及其用途 | |
| HU230364B1 (hu) | Simian adenovírus nukleinsav és aminosav-szekvencia, azt tartalmazó vektorok, és eljárások annak alkalmazására | |
| JP2024180560A5 (https=) | ||
| JP2020511165A (ja) | プログラム可能な腫瘍溶解性ウイルスワクチン系及びその適用 | |
| JP2008533988A5 (https=) | ||
| JP2023522154A5 (https=) | ||
| US10548973B2 (en) | Polypeptide carrier for presenting target polypeptide and uses thereof | |
| JP2019527036A (ja) | 改変糖タンパク質ｄを有するヘルペスウイルス | |
| EP4717766A1 (en) | Dendritic cell-targeted viroid dvlp, and preparation method therefor and use thereof | |
| JP2025513920A5 (https=) | ||
| JP2020526202A5 (https=) | ||
| WO2003006654A2 (en) | Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom | |
| CN118703545A (zh) | 一种促进iNKT细胞精准再识别iNKT免疫逃逸型胰腺癌肿瘤细胞亚群的基因线路 | |
| JP2024523329A5 (https=) | ||
| CN100462438C (zh) | 用于防御人体免疫缺陷病毒感染的嵌合的5型/11型或5型/35型腺病毒载体 | |
| CN116802280B (zh) | 不包括有复制能力的腺病毒的新型腺病毒载体及其用途 | |
| CN121319150B (zh) | 一种同时识别hbv核心抗原表位及包膜蛋白表位的tcr及其编码序列 |